Product Code: ETC10689282 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brazil Oncology Companion Diagnostics Market Overview |
3.1 Brazil Country Macro Economic Indicators |
3.2 Brazil Oncology Companion Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Brazil Oncology Companion Diagnostics Market - Industry Life Cycle |
3.4 Brazil Oncology Companion Diagnostics Market - Porter's Five Forces |
3.5 Brazil Oncology Companion Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Brazil Oncology Companion Diagnostics Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Brazil Oncology Companion Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Brazil Oncology Companion Diagnostics Market Revenues & Volume Share, By Sample Type, 2021 & 2031F |
4 Brazil Oncology Companion Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Brazil |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Technological advancements in companion diagnostics |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostics |
4.3.2 Limited reimbursement policies for companion diagnostics in Brazil |
5 Brazil Oncology Companion Diagnostics Market Trends |
6 Brazil Oncology Companion Diagnostics Market, By Types |
6.1 Brazil Oncology Companion Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Technology, 2021 - 2031F |
6.1.3 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.1.4 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By NGS-Based, 2021 - 2031F |
6.1.5 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By IHC-Based, 2021 - 2031F |
6.1.6 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By FISH-Based, 2021 - 2031F |
6.2 Brazil Oncology Companion Diagnostics Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Lung Cancer, 2021 - 2031F |
6.2.3 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.2.4 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.2.5 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Ovarian Cancer, 2021 - 2031F |
6.3 Brazil Oncology Companion Diagnostics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Research Centers, 2021 - 2031F |
6.3.4 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Diagnostic Labs, 2021 - 2031F |
6.3.5 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Brazil Oncology Companion Diagnostics Market, By Sample Type |
6.4.1 Overview and Analysis |
6.4.2 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Blood, 2021 - 2031F |
6.4.3 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Tissue, 2021 - 2031F |
6.4.4 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Saliva, 2021 - 2031F |
6.4.5 Brazil Oncology Companion Diagnostics Market Revenues & Volume, By Urine, 2021 - 2031F |
7 Brazil Oncology Companion Diagnostics Market Import-Export Trade Statistics |
7.1 Brazil Oncology Companion Diagnostics Market Export to Major Countries |
7.2 Brazil Oncology Companion Diagnostics Market Imports from Major Countries |
8 Brazil Oncology Companion Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics by oncologists in Brazil |
8.2 Number of clinical trials incorporating companion diagnostics |
8.3 Investment in research and development for new companion diagnostic technologies |
8.4 Number of partnerships between diagnostic companies and pharmaceutical companies for companion diagnostics |
8.5 Rate of integration of companion diagnostics into standard oncology treatment protocols in Brazil |
9 Brazil Oncology Companion Diagnostics Market - Opportunity Assessment |
9.1 Brazil Oncology Companion Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Brazil Oncology Companion Diagnostics Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Brazil Oncology Companion Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Brazil Oncology Companion Diagnostics Market Opportunity Assessment, By Sample Type, 2021 & 2031F |
10 Brazil Oncology Companion Diagnostics Market - Competitive Landscape |
10.1 Brazil Oncology Companion Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Brazil Oncology Companion Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |